IMNM Earnings Immunome Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–23 of 23
| Q2 2026 | 2026-06-30 | -1.12 | 2026-08-11 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.48 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -2.43 | 2026-03-03 | 10-K |
| Q3 2025 | 2025-09-30 | -1.68 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.02 | 2026-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.52 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -5.00 | 2026-03-03 | 10-K |
| Q3 2025 | 2024-09-30 | -3.72 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.97 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.51 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -5.38 | 2025-03-19 | 10-K |
| Q3 2024 | 2023-09-30 | -1.16 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.81 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.35 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -3.09 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -2.45 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.70 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.96 | 2023-05-05 | 10-Q |
| FY 2022 | 2021-12-31 | -2.14 | 2023-03-16 | 10-K |
| Q3 2022 | 2021-09-30 | -1.49 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.83 | 2022-08-05 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.37 | 2022-05-12 | 10-Q |
| FY 2021 | 2020-12-31 | -5.26 | 2022-03-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.